tiprankstipranks
Advertisement
Advertisement

ZYME Stock Latest News

Zymeworks and BeOne: Long‑Term Cancer Study Update Supports Durable Drug Story
Company AnnouncementsZymeworks and BeOne: Long‑Term Cancer Study Update Supports Durable Drug Story
7h ago
ONC
ZYME
Analyst Reaffirms Buy on Ziihera’s HER2+ GEA Strength, Maintains $46 Price Target Ahead of 2026 PDUFA
PremiumRatings
Analyst Reaffirms Buy on Ziihera’s HER2+ GEA Strength, Maintains $46 Price Target Ahead of 2026 PDUFA
12h ago
ZYME
Citizens biotech analysts hold a dinnermeeting at ASCO
PremiumThe Fly
Citizens biotech analysts hold a dinnermeeting at ASCO
12d ago
AZN
LLY
Zymeworks Earnings Call Balances Promise and Risk
PremiumCompany Announcements
Zymeworks Earnings Call Balances Promise and Risk
15d ago
ZYME
Zymeworks authorizes share repurchase program of up to $125M
PremiumThe Fly
Zymeworks authorizes share repurchase program of up to $125M
20d ago
ZYME
Zymeworks Authorizes 2026 Share Repurchase Program, Affirms Liquidity
PremiumCompany AnnouncementsZymeworks Authorizes 2026 Share Repurchase Program, Affirms Liquidity
20d ago
8K
ZYME
Zymeworks Maintained at Buy as Analyst Highlights Cash Runway, Upcoming Catalysts and Reiterates $46 Price Target
Premium
Ratings
Zymeworks Maintained at Buy as Analyst Highlights Cash Runway, Upcoming Catalysts and Reiterates $46 Price Target
24d ago
ZYME
Zymeworks’ Earnings Call Balances Progress And Pressure
Premium
Company Announcements
Zymeworks’ Earnings Call Balances Progress And Pressure
26d ago
ZYME
Zymeworks: Strong Ziihera Royalty Momentum and Deep Oncology Pipeline Underpin Buy Rating and Favorable Risk-Reward
PremiumRatings
Zymeworks: Strong Ziihera Royalty Momentum and Deep Oncology Pipeline Underpin Buy Rating and Favorable Risk-Reward
27d ago
ZYME
Zymeworks reports Q1 EPS (59c), consensus (10c)
PremiumThe Fly
Zymeworks reports Q1 EPS (59c), consensus (10c)
27d ago
ZYME
Zymeworks Reports Q1 2026 Results and Pipeline Progress
PremiumCompany Announcements
Zymeworks Reports Q1 2026 Results and Pipeline Progress
27d ago
8K
ZYME
Zymeworks: Buy Rating Reiterated as Priority Review for Zanidatamab Supports Upside; $46 Price Target Maintained
PremiumRatings
Zymeworks: Buy Rating Reiterated as Priority Review for Zanidatamab Supports Upside; $46 Price Target Maintained
1M ago
ZYME
Zymeworks: Buy Rating Reaffirmed on Zanidatamab Momentum and Royalty-Focused Model; $34 Price Target Maintained
PremiumRatingsZymeworks: Buy Rating Reaffirmed on Zanidatamab Momentum and Royalty-Focused Model; $34 Price Target Maintained
1M ago
ZYME
Zymeworks reports results from dose-escalation part of Phase 1 study for ZW191
Premium
The Fly
Zymeworks reports results from dose-escalation part of Phase 1 study for ZW191
1M ago
ZYME
Zymeworks Sets May 7 Date to Unveil Q1 2026 Results and Pipeline Update
Premium
Company Announcements
Zymeworks Sets May 7 Date to Unveil Q1 2026 Results and Pipeline Update
2M ago
ZYME
Zymeworks Bolsters Executive Team to Drive Next Phase of Growth
PremiumCompany Announcements
Zymeworks Bolsters Executive Team to Drive Next Phase of Growth
2M ago
ZYME
Zymeworks appoints new Head of R&D and Chief Business Officer
PremiumThe Fly
Zymeworks appoints new Head of R&D and Chief Business Officer
2M ago
ZYME
Leerink says Tubulis deal highlights value of ADC platforms like Sutro’s
PremiumThe Fly
Leerink says Tubulis deal highlights value of ADC platforms like Sutro’s
2M ago
GILD
IMNM
Zymeworks Names Kristin Stafford as New Chief Financial Officer
PremiumCompany Announcements
Zymeworks Names Kristin Stafford as New Chief Financial Officer
2M ago
ZYME
Zymeworks appoints Kristin Stafford as CFO
PremiumThe FlyZymeworks appoints Kristin Stafford as CFO
2M ago
NVCR
ZYME
Zymeworks (ZYME): Advancing ADC Platform, Fast-Track ZW191, and Broad FRα Opportunity Support Buy Rating
Premium
Ratings
Zymeworks (ZYME): Advancing ADC Platform, Fast-Track ZW191, and Broad FRα Opportunity Support Buy Rating
2M ago
ZYME
Zymeworks Wins FDA Fast Track Status for Ovarian Cancer Drug ZW191
Premium
Company Announcements
Zymeworks Wins FDA Fast Track Status for Ovarian Cancer Drug ZW191
2M ago
ZYME

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >